In patients with acute ischaemic stroke resulting from anterior circulation occlusion, endovascular therapy provides greater long-term benefits than does intravenous tissue plasminogen activator. However, further improvement of systems of care and research regarding adjunct therapies is still needed.
Refers to van den Berg, L. A. et al. Two-year outcome after endovascular treatment for acute ischemic stroke. N. Engl. J. Med. 376,1341-1349 (2017) | Davalos, A. et al. Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial. Lancet Neurol. 16, 369-376 (2017)